Kaplan-Meier curves stratified by LAPTM4B-35 expression and tumor stage or lymphovascular invasion revealed that LAPTM4B-35 positive patients have significantly poorer OS compared with LAPTM4B-35 negative ones in TNM stages I-III or without lymphovascular invasion subgroup. This evidence concerns the gene LAPTM4B and neoplasm.